Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients Response

被引：0
|
作者：
Wu, Tzong-Yow [1 ]
Chen, Pao-Yu [1 ,2 ]
Wang, Jann-Tay [1 ,3 ]
Liu, Wang-Da [4 ]
Chen, Yee-Chun [1 ,3 ,5 ]
Chang, Shan-Chwen [1 ,5 ]
机构：
[1] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan
[2] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan
[3] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan
[4] Natl Taiwan Univ, Dept Internal Med, Canc Ctr, Taipei, Taiwan
[5] Natl Taiwan Univ, Coll Med, Sch Med, Taipei, Taiwan
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2024年
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Assessment of SARS-CoV-2 specific t-cell response in immunocompromised patients failing to seroconvert in response to sars-cov-2 vaccine
    Wiercinska, E.
    Jarisch, A.
    Daqiq-Mirdad, S.
    Hellstern, H.
    Ajib, S.
    Cremer, A.
    Nguyen, N. T. T.
    Dukat, A.
    Ullrich, E.
    Ciesek, S.
    Chow, K. -U.
    Serve, H.
    Seifried, E.
    Bader, P.
    Boenig, H.
    Bug, G.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 309 - 310
  • [22] Combination treatment of persistent COVID-19 in immunocompromised patients with remdesivir, nirmaltrevir/ritonavir and tixegavimab/cilgavimab
    Brosh-Nissimov, Tal
    Ma'aravi, Nir
    Leshin-Carmel, Daniel
    Edel, Yonatan
    Ben Barouch, Sharon
    Segman, Yafit
    Cahan, Amos
    Barenboim, Erez
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2024, 57 (01) : 189 - 194
  • [23] Genotypic and predicted phenotypic analysis of SARS-COV-2 Omicron subvariants in immunocompromised patients with COVID-19 following tixagevimab-cilgavimab prophylaxis
    Ordaya, Eloy E.
    Vergidis, Paschalis
    Razonable, Raymund R.
    Yao, Joseph D.
    Beam, Elena
    JOURNAL OF CLINICAL VIROLOGY, 2023, 160
  • [24] Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infections
    Nooruzzaman, Mohammed
    Johnson, Katherine E. E.
    Rani, Ruchi
    Finkelsztein, Eli J.
    Caserta, Leonardo C.
    Kodiyanplakkal, Rosy P.
    Wang, Wei
    Hsu, Jingmei
    Salpietro, Maria T.
    Banakis, Stephanie
    Albert, Joshua
    Westblade, Lars F.
    Zanettini, Claudio
    Marchionni, Luigi
    Soave, Rosemary
    Ghedin, Elodie
    Diel, Diego G.
    Salvatore, Mirella
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [25] Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment
    Vellas, Camille
    Kamar, Nassim
    Izopet, Jacques
    JOURNAL OF INFECTION, 2022, 85 (05) : E162 - E163
  • [26] Tixagevimab/Cilgavimab for COVID-19 Pre-Exposure Prophylaxis in Hematologic Patients-A Tailored Approach Based on SARS-CoV-2 Vaccine Response
    Braitsch, Krischan
    Jeske, Samuel D.
    Stroh, Jacob
    Hefter, Maike
    Platen, Louise
    Bachmann, Quirin
    Renders, Lutz
    Protzer, Ulrike
    Goetze, Katharina S.
    Herhaus, Peter
    Verbeek, Mareike
    Spinner, Christoph D.
    Bassermann, Florian
    Hoegner, Marion
    Haller, Bernhard
    Schneider, Jochen
    Heider, Michael
    VACCINES, 2024, 12 (08)
  • [27] Assessing the post hoc effectiveness of tixagevimab-cilgavimab for prevention of SARS-CoV-2 infections in solid organ transplant recipients
    Jordan, Stanley C.
    Joung, Sandy Y.
    Wang, Minhao
    Tran, Teresa Anh
    Bravo, Michelle
    Masoom, Hibah
    Chang, Christine
    Mendez, Marilyn
    Patel, Jignesh
    Sun, Nancy
    Kittleson, Michelle
    Frias, Edwin
    Prostko, John C.
    Ebinger, Joseph E.
    Cheng, Susan
    Sobhani, Kimia
    TRANSPLANT INFECTIOUS DISEASE, 2024, 26 (01)
  • [28] Tixagevimab-cilgavimab as pre-exposure prophylactic treatment against SARS-CoV-2 in kidney transplantation patients
    Gonzalez-Blas, Luis Bravo
    Garcia, Natalia Menendez
    Prada, Maria Fernandez
    Fraile, Maria Gago
    Fernandez, Maria Luisa Suarez
    Cano, Natalia Ridao
    NEFROLOGIA, 2024, 44 (03): : 396 - 401
  • [29] Arguments in favour of remdesivir for treating SARS-CoV-2 infections
    Ko, Wen-Chien
    Rolain, Jean-Marc
    Lee, Nan-Yao
    Chen, Po-Lin
    Huang, Ching-Tai
    Lee, Ping-Ing
    Hsueh, Po-Ren
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (04)
  • [30] SARS-CoV-2 viral load dynamics in immunocompromised critically ill patients on remdesivir treatment
    Latimer, Tobias
    Erber, Johanna
    Schmid, Roland M.
    Schneider, Jochen
    Spinner, Christoph D.
    Luppa, Peter
    Soergel, Fritz
    Kinzig, Martina
    Rasch, Sebastian
    MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2022, 17
12345